Hormone shot boosts prospects of quick recovery from heart attackOctober 9th, 2008 - 2:12 pm ICT by IANS
Washington, Oct 9 (IANS) A single shot of erythropoietin or EPO, a hormone, administered just after a heart attack can drastically reduce the degree of damage to the organ’s muscle fibres, according to a study by Japanese scientists. EPO limits such damage by eliminating apoptosis or programmed cell death. “We wanted to see if the area of cell death following acute coronary occlusion (partial or complete obstruction of blood flow in coronary arteries) could be reduced by a single dose of EPO,” said H. William Strauss, physician at the Nuclear Medicine Service at Memorial Sloan Kettering Cancer Centre and co-author of the study.
“Although other drugs to inhibit apoptosis have been studied, none appears nearly as effective as a single dose of EPO,” Strauss said.
“Cells deprived of blood quickly begin to die. By administering 99mTc-annexin V, a radiotracer with a high affinity for apoptotic cells, we were able to view the effects of EPO on heart cells immediately following the restriction of blood flow that occurs during myocardial infarction (heart attack),” he said.
In the study, 18 Wistar rats were randomised into two groups. In both groups, arteries were blocked to induce a heart attack; 20 minutes later, they were unblocked, according to a release of the Society of Nuclear Medicine.
Immediately afterward, one group (treatment) received an EPO shot and the other group saline (non-treatment). Both groups were then injected with 99mTc-annexin V, and their hearts were examined using autoradiography to evaluate the distribution of the radiotracer.
In the treatment group, EPO therapy caused a 2.7-fold reduction of tracer accumulation, indicating a reduction in apoptosis (programmed cell death) and, therefore, less damage to heart tissue.
The reduction in damage to the heart was also demonstrated by measurement of regional cardiac function, which was significantly better in the EPO-treated group. These findings suggest that EPO may be useful to prevent long-term heart damage and dysfunction after a heart attack.
Co-authors of the study include Katsuichi Ohtsuki and Tomoki Doue, Kyoto Prefectural University of Medicine, Kyoto (Japan).
These findings were published in the October issue of The Journal of Nuclear Medicine.
- One dose of EPO can limit amount of damage to the heart following attack - Oct 09, 2008
- Sex hormone protects women from cardio risks - Aug 12, 2011
- Blood hormone Epo boosts motivation - Jun 12, 2012
- Garlic oil component protects heart - Nov 17, 2011
- Heart disease likely to pass from father to son - Feb 09, 2012
- New way to kill cancer cells discovered - Sep 18, 2011
- Stress could tell harder on women's hearts - Apr 25, 2012
- New technique to identify potential atherosclerosis risk found - Apr 12, 2011
- Patients' own stem cells could be used as treatment for their heart disease - Nov 18, 2010
- Protein that could be new target to reduce damage after heart attack identified - Feb 25, 2011
- Cholesterol levels in young adults predict future heart disease risk - Aug 03, 2010
- New approach could reverse liver failure - Aug 06, 2012
- Biomarker can nip hardening of arteries in the bud - Jan 22, 2012
- EPO doping 'can cut cerebral malaria related deaths' - Apr 22, 2011
- New cell therapy shows promise against atherosclerosis - Mar 02, 2011
Tags: apoptotic cells, coronary arteries, coronary occlusion, heart cells, memorial sloan kettering, nuclear medicine service, sloan kettering cancer, society of nuclear medicine, william strauss, wistar rats